Re:Goldman Sachs questions whether curing patients is a sust...
by chopin on Friday April 13, 2018 @07:04AM
(#16828811)
They may, but these institutions are keen on cures and not on treatments.
I am completely on the side of having government agencies developing cures and licensing out to companies then. This would avoid the perverse incentive of the OP. It also would stop the pervasive argument that patents are necessary to get new pharmaceuticals developed (I don't believe in patents benefit to society).
I am completely on the side of having government agencies developing cures and licensing out to companies then. This would avoid the perverse incentive of the OP. It also would stop the pervasive argument that patents are necessary to get new pharmaceuticals developed (I don't believe in patents benefit to society).